← Back to Search

Video-Feedback Interaction Guidance for Postpartum Depression (VID-KIDS Trial)

N/A

Waitlist Available

Led By Nicole L Letourneau, RN, PhD

Research Sponsored by University of Calgary

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Timeline

Screening 3 weeks

Treatment Varies

Follow Up through study completion, an average of 18 weeks

Awards & highlights

VID-KIDS Trial Summary

This trial is testing whether a nurse-guided video feedback intervention can improve mother-infant interactions in the context of postpartum depression, and in turn, improve infant cortisol patterns and development.

Who is the study for?

This trial is for mothers with postpartum depression, indicated by a score greater than 12 on the Edinburgh Postnatal Depression Scale, and who have infants aged 2-6 months. Mothers taking antidepressants or undergoing other PPD treatments can join, but not those receiving certain other parenting services.Check my eligibility

What is being tested?

The VID-KIDS program aims to improve interactions between depressed mothers and their infants. It uses nurse-guided video feedback to enhance mother-infant exchanges which are crucial for healthy child development and may reduce stress hormone effects in infants.See study design

What are the potential side effects?

Since this intervention involves behavioral guidance rather than medication, traditional side effects are not expected. However, participants may experience emotional discomfort or distress during the process of reflecting on their interactions.

VID-KIDS Trial Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ through study completion, an average of 18 weeks

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~through study completion, an average of 18 weeks

This trial's timeline: 3 weeks for screening, Varies for treatment, and through study completion, an average of 18 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

NCAST assessment scale will be used to evaluate Mother-Infant (M-I) interactions

VID-KIDS Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: VID-KIDS Intervention Program GroupExperimental Treatment1 Intervention

RN review photos of infant engagement/disengagement cues. NCAST Teaching Activity, mothers asked to perform task advanced for infant's level, recorded. 1st-View, no feedback, mothers reveal infant cues. RN records infant/mother's response, later discussion. 2nd, RN and mother co-view interaction with time for replay/review parts of sensitivity and responsiveness. RN feedback: praising desired maternal behaviours; information on infant cues; maternal response to infant distress; and use of cognitive growth fostering language. 3rd, all concepts discussed in past views, use positive reinforcement to affirm aspects of sensitivity, useful feedback for areas of growth. Post-Debrief, RN and mother discuss interests of the mother. Mothers encouraged to note infants' engagement/disengagement cues.

Group II: Control GroupActive Control1 Intervention

Mothers will receive standard care such as referral to psychotherapy (intervention mothers will have the same access) over the same length of time.

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

VID-KIDS Intervention Program

2021

N/A

~20

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

Alberta Health servicesOTHER

157 Previous Clinical Trials

649,181 Total Patients Enrolled

1 Trials studying Postpartum Depression

20 Patients Enrolled for Postpartum Depression

University of CalgaryLead Sponsor

787 Previous Clinical Trials

845,908 Total Patients Enrolled

2 Trials studying Postpartum Depression

20 Patients Enrolled for Postpartum Depression

Nicole L Letourneau, RN, PhDPrincipal InvestigatorUniversity of Calgary

Media Library

VID-KIDS Intervention Program Clinical Trial Eligibility Overview. Trial Name: NCT03052374 — N/A

Postpartum Depression Research Study Groups: Control Group, VID-KIDS Intervention Program Group

Postpartum Depression Clinical Trial 2023: VID-KIDS Intervention Program Highlights & Side Effects. Trial Name: NCT03052374 — N/A

VID-KIDS Intervention Program 2023 Treatment Timeline for Medical Study. Trial Name: NCT03052374 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there vacancies within this clinical research program?

"As per information found on clinicaltrials.gov, the recruitment drive for this study has been concluded. Initially posted in May 2017 and last updated in October 2022, 1151 other trials remain open to new participants right now."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Video-Feedback Interaction Guidance for Improving Interactions Between Depressed Mothers and Their Infants ("VID-KIDS")

Nicole Letourneau 2017. "Video-Feedback Interaction Guidance for Improving Interactions Between Depressed Mothers and Their Infants ("VID-KIDS")". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT03052374.